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Marked hypercholesterolemia is regularly manifested by rabbits and certain 
other animals fed diets containing added cholesterol, and it is well known that 
such cholesterol-fed animals frequently develop atherosclerosis (173).  Yet the 
mechanism  whereby  cholesterol  feeding induces atherosclerosis remains un- 
disclosed, and a  number of facts have made it seem doubtful that hypercho- 
lesterolemia per se causes atherosclerosis, either natural or experimental (4, 5). 
The experiments now to be reported were undertaken to learn more about the 
relationship of elevated blood lipids, particularly the blood phospholipids, to 
the development of experimental atherosclerosis. 
Our interest in the possible role of blood phospholipids in the pathogenesis 
of atherosclerosis originated from the observation that the serum cholesterol 
levels of cholesterol-fed rabbits with atherosclerosis were usually elevated in 
amount and in addition were regularly higher than were the serum phospho- 
lipid levels of the same animals (6, 7), this representing a reversal of the normal 
situation in the rabbit in which the serum phospholipid level is usually slightly 
higher than the cholesterol level (6, 8). Since the phospholipids had been shown 
by Boyd (9) to play an important part in maintaining the stability of the serum 
lipid emulsion--a fact subsequently confirmed and extended by Ahrens and 
Kunkel (10)nit seemed possible that the serum cholesterol in atherosclerofic 
animals, in addition to being markedly increased in amount, may also have been 
relatively unstable in view of the lack of a parallel increase in the phospholipid, 
and that this might be  an  important factor in  the  development of the  ex- 
perimental atherosclerosis. More recently we have found that significant in- 
creases in  serum  lipid  content,  and  particularly notable  increases  in  serum 
phospholipid levels, regularly follow the intravenous injection of two surface- 
active agents into rabbits on a  normal cholesterol-free diet (11).  We were led 
therefore to study in detail the effects of the intravenously administered sur- 
* This work was aided by grants from the United States Public Health Service and the 
New York Heart Association. 
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face-active  agents  on  the  development  of  atherosclerosis  in  cholesterol-fed 
rabbits and  the relationship  of increased  blood phospholipids  to  the  process. ~ 
Materials and Methods 
Market-bought rabbits of mixed breed, weighing between 2,050 and 4,150 gm., and equally 
divided between males and females, were used. All animals were fed a stock diet of Rockland 
rabbit pellets,  to which powdered cholesterol or cholesterol and Tween  80  ~ were added in 
amounts to be indicated further on.  The animals fed cholesterol and  those fed cholesterol 
together with Tween 80 had these substances added to their diets on alternate days  three 
times a  week. A weighed amount of cholesterol and a  measured amount of Tween 80 were 
added to the pellets in individual food cups and thoroughly mixed. The same cup wasused for 
each animal and was not emptied during the course of the experiment. On the intervening 
days plain pellets were added to the residue in the cup, so that practically all the cholesterol 
and Tween 80 administered to a  particular rabbit was eventually consumed. Tween 80 was 
added to the oral cholesterol in some of these experiments because our experience with this 
substance had indicated that when fed to rabbits without added cholesterol it produced no 
significant change in blood lipids, but when given with cholesterol it enhanced the absorption 
of the cholesterol and resulted in more rapid and more marked elevation of blood cholesterol 
levels and the more certain development of atheroselerosis (12). 
The surface-active agents injected intravenously were Tween 80 and Triton A20.  3 Solu- 
tions of these agents for intravenous use were prepared as previously described (11). 
The rabbits were bled just prior to the start of  each  experiment  and  at  periodic  inter- 
vals thereafter, and the levels of blood lipids were determined by procedures  described  pre- 
viously (11). 
It was felt necessary to follow the weights of the animals very carefully because of the ob- 
servations of Firstbrook that a  decrease in body weight may interfere with the development 
of atherosclerosis in cholesterol-fed rabbits (13). Hence the animals were weighed at the start 
of each experiment and at intervals thereafter. 
Complete postmortem examinations were performed on all animals. The heart and entire 
aorta were removed ~  bloc, and after fixation in 4 per cent formaldehyde, were stained with 
Sudan IV to accentuate the atherosclerotic areas, which regularly took on an orange-red color. 
The degree of atherosclerosis of the aorta visible in the gross was estimated on an arbitrary 
scale from 0 to ++-I-q-, where 0 represents absence of visible atherosclerosis; +  represents 
minimal, just visible atherosclerofic streaks or plaques; q-+q--F represents extensive cover- 
ing of most of the intimal surface of the aorta with numerous, coalescent, raised plaques; 
and grades ++  and +q-q- are intermediate between the latter two. Sections for microscopic 
study were taken from selected sites in those instances in which it was felt necessary to con- 
firm the presence or absence of minimal atherosclerosis, and, in addition, from representative 
lesions of all grades of severity. The minimal lesions consisted for the most part of slightly 
raised intimal plaques containing clusters of foam cells; these plaques increased progressivey 
in thickness and extent in the more advanced lesions, and in those graded as q--b++,  were 
almost as thick as the media. In the latter lesions, too, the outlines of the foam cells frequently 
could not be seen, the cells appearing to be degenerated, and in a few such cases early hyaliniza- 
tion and calcification of the intima were evident. 
I For preliminary note see Fed. Proc., 1949,  8, 360. 
Polyoxyalkylene  sorbitan  monooleate,  manufactured  by  the Atlas  Powder  Co.,  Wil- 
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The Effects on Cholesterol-Fed Rabbits of Repeated Intravenous Injections 
of Tween 80 
An  experiment  was  first  done  to  learn  the  effects of  intravenously  admin- 
istered Tween 80 on the blood cholesterol and  phospholipid  levels and  on  the 
development  of  atherosclerosis  in  cholesterol-fed rabbits. 
Three groups of animals were included in this experiment. Group I consisted of seven con- 
trol rabbits  that were fed the normal diet to which 0.5 gin. of cholesterol was added  three 
times weekly. Group 2 consisted of five rabbits that were maintained on a normal diet, with- 
out added cholesterol, and were given twice daily intravenous injections of 7.5 cc. of 20 per 
cent Tween 80. Group 3 consisted of six rabbits that were fed 0.5 gm. of cholesterol three times 
weekly, and were in addition given intravenous injections of Tween 80 in the same  amounts 
as the animals of group 2. Injections were given daily at about 9:00 a.m. and  again at about 
4:30 p.m., except on Saturdays, when the afternoon injection was omitted,  and on Sundays, 
when no injections were given. The duration of the experiment was 13 weeks. Samplesof blood 
for lipid determination were taken every 3 weeks, on  Monday mornings prior to theinjection 
of Tween 80. 
It will be noted that the rabbits of group 1 (cholesterol-fed but not injected  with Tween 
80---see Table I) manifested only very slight elevations of the  serum cholesterol and  serum 
phospholipid  levels 3  weeks after  the cholesterol feeding had  been  started.  After 6  weeks 
there were moderate elevations of these levels in all animals in this group and  the hyperlipemia 
persisted thereafter, it being noteworthy that the level of blood cholesterol eventually exceeded 
that of the phospholipid in every animal. Five of the seven animals had atherosclerosis when 
they were examined postmortem at the end of the experiment, this being slight in three in- 
stances and moderate in two. 
The rabbits of group 2 (given Tween 80 intravenously but not fed cholesterol) manifested 
a  marked hyperlipemia which differed from that of group 1 in several respects: it appeared 
more promptly, being quite marked 3 weeks after the experiment had been started; the lipid 
levels were considerably higher, the amounts of cholesterol and phospholipid in the serum of 
the animals in this group in almost every case greatly exceeding those present in the rabbits 
of group 1; furthermore, the hyperlipemla differed qualitatively in that the phospholipid was 
regularly greater in amount than was the cholesterol in the serum of these animals. None of the 
rabbits in group 2 exhibited atherosclerosis of the aorta when examined at the end of the ex- 
periment. 
The rabbits of group 3 (cholesterol-fed and given Tween 80 intravenously) all manifested a 
hyperlipemla which again was marked after 3 weeks and remained so thereafter, the levels 
of cholesterol and of phospholipid being appreciably higher in nearly every animal than was 
observed in the rabbits of groups 1 and 2. It is noteworthy that the phospholipid levels were 
regularly higher than were the cholesterol levels, as was the case in the rabbits of group  2. 
The tendency of the blood lipid levels to decrease after the 9th week, present in all the animals 
of group 3 and in some of the animals of group 1, has been observed previously in the hyper- 
lipemia that follows cholesterol feeding in rabbits and has been attributed  to impairment of 
absorption  of  cholesterol  due  to  extensive infiltration  of  lipids  into the mucosa of the 
intestine (14). Only one of the four rabbits in group 3 that survived to the end of the experi- 
ment had  atherosclerosis of the aorta,  and  that was very slight. 
It is apparent  from  the findings  of this experiment  that  little or no athero- 
sclerosis  developed  in  the  Tween  80-injected  rabbits  of  group  2  and  in  the 
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had more marked and more sustained hypercholesterolemia than did the cho- 
lesterol-fed control rabbits of  group  1  (Table I).  It is  noteworthy that  the 
amount of phospholipid in the blood of these Tween 80-injected animals regu- 
TABLE I 
E.~ec~ of Intrarmous  Tgccn 80 on Serum Lipids and  on the D~velopment of Athero~clerosis in 
Rabbits  Fed High Cholesterol and  Normal  Diets 
Level of serum lipids 
t.  Control  rabbits  1 
given  cholesterol 
diet, and no Tweev 
80 intravenously  2 
L Experimental rab- 
bits given normal 
diet,  and  Tween 
80  intravenously 
twice daily 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Initial [  Final  0  3  6  9  12 
i 
kg.  kg. 
2.05  3.75  Chol  47  35  138  119129  94  0 
PL  77  55  100  93  97  84 
2.85  3.78  Chol  47  50  116  123284  124  0 
PL  103  53  127  97 267  129 
4.15  4.80  Chol  28  88  216  260294  177  + 
PL  40  60  107  100 163  94 
3.88  4.48  Chol  100110 247  423 530  282  -b 
PL  ]143 93  153  200337  185 
2.90  3.38  Chol  48  65  265  250212  168  q- 
PL  83  88  148  120123  112 
2.83  3.48  Chol  47 135  2231  284138  165  q--b 
PL  65  88  123  158103  107 
2.30  4.23  Chol  68 123  341  329 239  220  q-q- 
PL  95 108  145  133 138  L~4 
I-- 
3.75  3.95  Chol  47 229  654[ 463 550  389  0 
PL  97 355  7201 703!850  546 
2.85  4.33  Chol  60 169  229  375 232  213  0 
PL  100 255  400  647 470[  374 
2.78  3.33  Chol 42275  678  1131530  328  0 
PL  73 435  750  265 650  435 
2.70  3.48  Chol  371297 429  445[688  379  0 
PL  771467 445  565940  499 
2.80  4.10  Chol  65 241  281  290 263  228  0 
PL  97 323  415  305 44C  316 
Experimental group  Rabbit  Weight  Athero-  No.  Time, ~ks.  sclerosis 
Mean*  of aortal: A.  KELLNER, J.  W.  CORRELL, AND A.  T.  LADD  389 
TABLE I--Concluded 
Experimental group 
L Experimental rab- 
bits given choles- 
terol  diet  and 
Tween  80  intra- 
travenously  twice 
daily 
Rabbit 
No. 
! 
13 
14 
15 
16 
17 
18 
Weight 
Initial  Final 
kg.  kg. 
2.73  3.20 
2.85  3.38 
3.0  3.50 
2.78  3.45 
3.23  3.33 
3.1  3.1 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Level of serum lipids 
Time, wks. 
0  3  6  9  12 
39 582  731  957 675 
83 445  818 1105 720i 
37 319  485  450 32C 
53 320  625  465390 
63 338  566  557 507 
70 493  473  665 570 
47 342  948 108G 545 
i 
951335 1235 12~ ~60 
43 28.5 488  435  t 
68 450  458  488 
44 313  t 
83t00 
M-can* 
592 
684 
371 
408 
454 
773 
Athero- 
sclerosis 
of aortat 
+ 
Group 1. Cholesterol 0.5 gin. 3 times weekly for 13 weeks. 
Group 2.  7.5 cc. of 20 per cent Tween 80 intravenously twice daily for 13 weeks. 
Group 3.  Cholesterol 0.5 gin. 3 times weekly  ~ for 13 
weeks.  7.5 cc. of 20 per cent Tween 80 intravenously twice daily J 
0 =. just prior to beginning of experiment. 
Chol =  total serum cholesterol, rag./100 ¢c. 
PL  ffi phospholipid expressed as lecithin, rag./100 c¢. 
t  •"  died. 
* The figures for  mean cholesterol and mean phospholipid  represent  the  arithmetical 
average of the respective lipid levels determined for each animal during the course of the 
experiment, including those obtained just prior to the start of the experiment. They are given 
here and in the succeeding tables primarily  to facilitate  comparison with the data of other 
workers. 
As determined  on  postmortem  examination  at  the  end of  the 13th  week. 
larly exceeded that of the cholesterol. Consideration will be given further on to 
the implications of these observations. These findings have recently been con- 
firmed by Payne and Duff, as indicated in a  preliminary report (15). 
Blood Lipid Levels and Atherosclerosis of the Aorta of Ckolesterol-Fed 
Rabbits Injected Intravenously witk Triton A20 
In studies reported in an accompanying paper (11) it was shown that Triton 
A20  is  more  effective  than  Tween 80  in  inducing hyperlipemia when given 390  SIYR~'ACE*ACTIV'E AGENTS  AND  ATtt'EROSCLEROSIS 
intravenously to rabbits on a cholesterol-free diet, and that this surface-active 
agent gives rise to increases in blood phospholipid and blood cholesterol content 
that  are greater  and  more  enduring  than  are  those resulting  from Tween  80. 
It therefore seemed probable  that more definitive observations might be made 
on the relationship between hyperlipemia and atherosclerosis in animals given 
this  agent.  Furthermore,  since  the  cholesterol-fed control  animals  in  the  pre- 
ceding experiment exhibited only slight to  moderate degrees of atherosclerosis 
it was  thought  desirable  in  the experiment now to be described  to attempt  to 
accentuate  the development of atherosclerosis by the addition of Tween 80 to 
the diet of all animals fed cholesterol, as had been done in previous work  (12). 
For the purposes of this experiment forty-one rabbits were divided into four groups, num- 
bered 4, 5,  6,  and  7.  Group 4 consisted of eleven control animals that were fed the stock 
diet to which 1.0 gm. of cholesterol and l0 cc. of Tween 80 were added three times a week; 
these animals received no Triton A20 intravenously. Group 5 consisted of eleven rabbits that 
were maintained on the stock diet without added cholesterol or Tween 80, and that received 
twice weekly intravenous injections of 4 cc. of 12.5 per cent Triton A20. There were eleven 
rabbits in group 6 and eight in group 7; each animal received twice weekly intravenous in- 
jections of Triton A20 in the same dose given to group 5. In addition, the animals in group 6 
had 0.5 gin. of cholesterol and 4 cc. of Tween 80, and those in group 7 had 1.0 gin. of cholesterol 
and 10 cc. of Tween 80, added to their stock diet three times a week. The duration of the feed- 
ing plus injection was 9 weeks in each case. 
The observations on blood lipid levels and  aortic atherosclerosis in these four groups of 
animals are summarized in Tables II, III, IV, and V. The control rabbits of group 4  (fed 
cholesterol and Tween 80 but not injected with Triton A20---see Table II) had marked eleva- 
tions of blood cholesterol and phospholipid 2 weeks after the start of the experiment, and these 
persisted for the duration of the experiment. It is of considerable interest that in each animal 
the level of blood cholesterol exceeded that of the blood phospholipid at every determination 
following the initial one taken at the beginning of the experiment. When examined postmortem, 
every animal in this group had atherosclerosis of the aorta, and in five of them the athero- 
sclerosis was marked. 
The rabbits of group 5 (given Triton A20 intravenously but not fed cholesterol--see Table 
III) manifested sustained elevations of blood cholesterol and phospholipid levels throughout 
the course of the experiment, and these elevations were in general of the same order of magnl- 
tude as were those of the animals of group 4, with the important difference that in the rabbits 
of group 5 the levels of blood phospholipid in most instances exceeded that of the blood cho- 
lesterol. Six of the animals in this group had no atherosclerosis of the aorta at the end of the 
experiment, four had very slight lesions, and only one had extensive lesions. The aortic lesions 
in these animals were similar in distribution and morphology to those observed in the cho- 
lesterol-fed rabbits of group 4. 
The rabbits of groups 6 and 7 (fed cholesterol admixed with Tween 80 and alBo given Triton 
A20 intravenously---see Tables IV and V) had sustained elevations of the blood cholesterol 
level that in general were slightly greater than those observed in the control animals of group 
4. It is of interest that the blood phospholipid levels of these animals, while consistently ele- 
vated, were nevertheless in almost every instance somewhat lower than the  corresponding 
cholesterol levels, though  the disparity  between cholesterol and  phospholipid in these two 
groups of animals was considerably less  than that noted in the case of the controls  (Table 
II). Seven of the animals in these two groups had no atherosclerosis of the aorta at  the end of 
the experiment and twelve animals had aortic lesions that were slight to moderate in severity A.  KELLNER~  J.  W.  CORRELL,  AND  A.  T.  LADD  391 
TABLE II 
Group 4. Serum Cholesterol and Phospholipid Levds and Atherosderosis of the Aorta of Rabbi~s 
Fed a High Cholesterd Diet* 
Rabbit 
No, 
10 
11 
Weight 
Initial  Final 
kg.  kg. 
2.89  3.65 
3.90  3.78 
2.83  3.43 
2.65  3.28 
2.48  3.13 
J 
I 
3.18[  4.0 
i 
I 
i 
2.18  ]3.50 
i 
2.55  2.63 
2.68  3.0 
2.50  2.98 
3.10  3.08 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Level of serum lipids 
0 
73 
85 
5O 
78 
134 
108 
43 
9O 
59 
103 
66 
103 
66 
98 
30 
58 
37 
75 
84 
88 
48 
80 
Time, wks. 
I  2 
I 231  I 
1135 
I 
311 
183 
775 
353 
153 
105 
398 
175 
632 
463 
426 
243 
631 
473  i 
329 
225 
469 
260 
637 
453 
t 
l 
4  ]6 
1-- 
413  i  361  412[ 
170  200  223 
1280  382  297  464 
588  173  195  243 
883  597  412  560 
328  348  243  276 
386  289  143  203 
195  175  90  181 
487  760  341 
303  463  240  I 
1058  1382  974 
620  710  495 
873  1230 
585  833 
1295  1132 
815  848 
545  774 
300  555 
719!  822 
468  490  ] 
1062  1067 
710  715 
826 
508 
1079 
765 
339 
200 
J 
539 
3O5 
849 
493 
i 
Mean 
298 
163 
409 
257 
8~ 
478 
684 
453 
833 
405 
271 
589 
733 
490 
Atheroscle- 
rosis of aorta: 
+ 
+ 
+ 
++ 
++ 
++ 
+++ 
+++ 
++++ 
++++ 
++++ 
0  =  just prior to beginning of experiment. 
Chol ffi total serum cholesterol, mg./100 cc. 
PL  =  phospholipid expressed as lecithin, rag./100 cc. 
*  Cholesterol 1.0 gm.~ 
Tween 80  10  cc.  J  3 times weekly for 9 weeks. 
$ As determined postmortem at the end of the 9th week of  the experiment. The same is 
tree in the animals of Tables III, IV, and V to follow. 392  SURFACE-ACTIVE  AGENTS  AND  ATHEROSCLEROSIS 
It is noteworthy that the Triton-injected animals with only a few exceptions gained  weight 
during the course of the experiment, the observation serving to rule out weight loss as a possi- 
ble cause for the failure of these animals to develop as much atherosclerosis as did the controls. 
TABLE III 
Group 5. Serum Cholesterol and Plmspl~lipid L~ds and Ath~osclerosis of the Aorta of Rabbits 
Fed a Normal Diet and Given Repeated Intravenous Injections of Triton A20* 
Rabbit No. 
10 
11 
Weight 
Initial  Final 
I- 
kg.  kg. 
2.70  2.88 
2.50  2.55 
2.43  2.63 
2.83  3.18 
3.18  3.53 
3.13  2.68 
3.20  3.35 
2.68  2.88 
2.40  2.33 
2.40  2.65 
2.80  2.88 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL  ] 
Chol 
[  PL 
Chol 
PL 
Level of serum lipids  Atheroscle- 
Time, wks.  rosis  of  aorta 
0  3  6  [ 
r 
40  293  351 
53  323  353 
44  487  463 
53  628:  48O 
68  379  556 
70  438  700 
105  370  567 
55  393  488 
76  638  845 
75  475  765 
122  1008:1640 
83  1030  2410 
106  242  540 
I10  240  555 
116  262  910 
105  270  868 
74  516  770 
70  698  850 
34  710  890 
43  598  I000 
21  251  582 
43  245  478 
Mean 
9 
574  315  0 
668  349 
756  438  0 
880  510 
825  457  0 
1050  564 
J 
715  489  0 
748  421 
1090  662  0 
1370  671 
2550  1380  0 
2340  1466 
56O  862  + 
573  $70 
577  466  q- 
625  467 
842  551  + 
1130  887 
1025  885  + 
1330  746 
585  88O  +++ 
513  320 
* 4 cc. of 12.5 per cent Triton A20 intravenously twice weekly for 9 weeks. 
The findings of the experiment as a whole make it clear that the rabbits given 
Triton  A20  intravenously,  whether  maintained  on  a  normal  diet  (Table  III) A. KELLNER, 3. W. CORRELL, AND A. T. LADD  393 
TABLE IV 
Group 6. Serum Cholesterol and Phospholipid  Levels and Atherosclerosis of the Aorta of Rabbits 
Fed a High Cholesterol Diet*  and Given Repeated Intravenous  Injections  of Triton A20~ 
Rabbit No. 
10 
11 
Weight 
Initial  Final 
kg.  kg. 
2.53  3.03 
2.70  2.63 
2.35  2.48 
3.00  2.88 
3.20  3.65 
2.56  2.88 
2.48  3.00 
2.93  3.05 
2.45  2.65 
2.53  2.73 
3.03  3.16 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Chol 
PL 
Level of serum lipids 
Time, wks. 
0  3  6  9 
81  199  400  475 
85  158  240  443 
42  493  610  1240 
48  463  608  1143 
35  578  1040  1560 
43  528  1050  1540 
78  1020  1670  1882 
60  930  1240  1560 
I 
35  228  332  585 
40  203  295  565 
60  236  570  415 
83  218  365  425 
43  550  458  715 
63  318  313  703 
36  254  575  617 
60  250  395  460 
30  660  994  1180 
48  548  885  1040 
55  755  1220  1170 
65  645  1013  1260 
77  781  1010  1880 
98  663  728  1520 
I 
~/~eall 
280 
232 
566 
804 
7OO 
1160 
948 
~75 
$20 
273 
442 
349 
371 
201 
716 
63O 
800 
745 
9S7 
752 
Atheroscle- 
rosis of aorta 
+ 
+ 
+ 
++ 
++ 
+4- 
-t--L 
* Cholesterol 0.5 gm.~ 3 
Tween 80  4  cc.  )  times weekly for 9 weeks. 
4 co. of 12.5 per cent Triton A20 intravenously  twice weekly for 9 weeks. 
or on  a  diet containing added  cholesterol (Tables  IV and  V),  developed less 
atherosderosis of the aorta than did the control animals that were fed choles- 
terol but were not given Triton A20 intravenously (Table II). It is noteworthy 
that this decrease in the incidence and severity of atherosclerosis in the Triton- 394  SURI~ACE-ACTIVE AGENTS AND ATttEROSCLEROSIS 
injected rabbits occurred  despite the  fact that  these animsls had  blood cho- 
lesterol levels that in general were as high as, and in many instances were far 
higher than, those of the controls. Furthermore, the lipemia manifested by the 
Triton-injected animals differed strikingly from that of the cholesterol-fed con- 
TABLE V 
Group 7. Serum Cholesterol and Phospholipid L~oels and Atherosclerosis of tt~ Aorta of Rabbits 
Fed a High  :kolesterol Diet* and Given Repeated Intravenous Injections of Triton A20~ 
Level of serum lipids 
Weight 
Chol 
PL 
Initial I Final 
1 
kg.  kg. 
2.88  3.23  Chol 
PL 
3.20  Chol 
PL 
2.91  Chol 
PL 
3.00  Chol 
PL 
3.55  Chol 
PL 
3.28  Chol 
PL 
3.18  Chol 
PL 
3.21 
Time, tvks. 
5  f73 
78  495  30 
$5 
125 
158 
81 
80 
78  1010 
95  913 
[19  1295 
[13  1058 
76  657 
8O  435 
[03  929 
L08  678 
1355 
84O 
2025 
1445 
65  313 
70  278 
Rabbit No. 
650 
495 
792 
758 
913 
1215 
467 
558 
5OO 
453 
682 
)4 
~5 
lO 
t3 
~0 
~5 
$2 
668  495 
1390  1158 
1023  830 
373  382 
330  263 
Atheroscle- 
rosis of aorta 
Mean 
413  0 
325 
669  0 
663 
849  0 
857 
486  + 
'  381 
529  + 
44O 
781  + 
695 
1163  ++ 
845 
283  ++ 
235 
* Cholesterol  1.0 gm.~ 
Tween 80  10  ec.  f 3 times weekly for 9 weeks. 
:~ 4 cc. of 12.5 per cent Triton A20 intravenously twice weekly for 9 weeks. 
trols; for in the former (Tables III, IV, and V) the level of the blood phospho- 
lipids was usually elevated to about the same degree as was that of the blood 
cholesterql, whereas in the latter (Table II) there was regularly a  marked dis- 
parity between the levels of the blood phospholipids and the blood cholesterol, 
these cholesterol-fed control animals in every instance having a high cholesterol A.  KELLN'ER,  J.  W.  CORRELL~  AND  A.  T.  LADD  395 
level and a relatively low phospholipid level. It is evident from this experiment 
that the level of the blood cholesterol was not the only factor involved in the 
pathogenesis of the atherosclerosis, and the data indicate further that the level 
of  the  blood  phospholipids,  particularly  the  relationship  between  the  blood 
cholesterol and phospholipids, may be an important additional factor involved 
in this process. 
The  atherosclerosis  manifested  in  the  Triton-injected  rabbits  of  group  5 
(Table III) is of particular interest because hitherto this lesion has been pro- 
duced experimentally in rabbits only by the addition of cholesterol to the diet 
or by the intravenous injection of cholesterol emulsions (16).  The lesions ob- 
served in this experiment represent the first production  of atherosclerosis in 
the rabbit without the introduction of exogenous cholesterol into the animal 
Attempts to Accelerate the Regression  of Experimental Atherosclerosis  by Means 
of Intravenously Injected Tween 80 
Spontaneous regression of experimentally produced atherosclerosis following 
the cessation of cholesterol feeding has been demonstrated in rabbits, chickens,. 
and dogs (1, 17, 18); the process in the rabbit, however, is a very slow one and 
requires many months for appreciable changes to take place.  In view of the 
mobilization  of  lipids  brought  about  by  the  intravenous  administration  of 
Tween 80,  the following experiment was designed to see whether the injection 
TABLE  VI 
Attempts to Accderate Resorption of Atheroscler  osis in Rabbits by Means of Repeated Intra~enou, 
Injection, of Tween 80 
Group 8  Group 9  Group I0 
Rabbit No.  Atherosclerosis  Rabbit No.  Atberosclerosis 
of aorta  of aorta 
+++ 
++ 
++ 
++ 
++ 
++++ 
++ 
Rabbit No.  Atherosclerosis 
of aorta 
8  ++++ 
9  ++++ 
10  ++ 
11  +++ 
12  ++++ 
13  +++ 
14  ++ 
15  +++ 
16 
17 
18 
19 
20 
21 
22 
23 
++++ 
++++ 
+++ 
+ 
+++ 
++ 
++ 
+++ 
Group 8. Cholesterol 1.0 gin. and Tween 80 10 cc. 3 times weekly for 8 weeks. 
Group 9. Cholesterol 1.0 gin. and Tween 80 10 cc. 3 times weekly for 8 weeks. Normal 
diet for 8 weeks. 
Group 10. Cholesterol 1.0 gin. and Tween 80 10 cc. 3 times weekly for 8 weeks. 7.5 cc. 
of 20 per cent Tween 80 intravenously twice daily for 8 weeks. 396  SURFACE-ACTIVE  AGENTS  AND  ATHEROSCLEROSIS 
of this agent would accelerate the regression of previously induced cholesterol 
atherosclerosis in the rabbit. 
Twenty-three rabbits were fed 1.0 gm. of cholesterol and 10 cc. of Tween 80 three times a 
week for 8 weeks. At this time seven rabbits were killed and the degree of atherosclerosis of 
the aorta determined (group 8). The remaining sixteen animals were maintained for 8 more 
weeks on the  stock  diet  without  added  cholesterol or  Tween 80  (groups 9  and 10), 
eight of these sixteen animals receiving in  addition twice daily intravenous injections of 
7.5 cc. of 20 per cent Tween 80 (group 10). At the end of the second 8 week period the an- 
imals were sacrificed and the degree of atherosclerosis of the aorta noted. 
The findings of this experiment are recorded in Table VI. It is evident that 
there  was  no  significant  difference in  the  incidence  and  severity of  athero- 
sclerosis in the animals which received intravenous  Tween  80 for 8 weeks as 
compared with  those  of  the  control  groups which  did  not.  It was therefore 
concluded that under the conditions of the experiment intravenously adminis- 
tered  Tween  80  did  not  accelerate resorption  of previously existing  athero- 
sclerosis in  rabbits.  These  results  are  not  unlike  those  of Duff  (5)  who has 
reported  that  alloxan  diabetes retards  the  development of atherosclerosis  in 
cholesterol-fed rabbits but does not accelerate resorption of the lesions. 
DISCUSSION 
In  the  experiments  here  described  the  incidence  and  severity of athero- 
sclerosis were decreased in cholesterol-fed rabbits given repeated intravenous 
injections of the surface-actlve agents Tween 80 and Triton A20, as compared 
with those found in control rabbits fed the same cholesterol diet.  It is note- 
worthy that atherosclerosis often failed to develop in  the  animals given  the 
surface-active agents intravenously even when  they exhibited  a  marked and 
sustained hypercholesterolemia. Whether the blood phospholipids, which were 
also greatly increased in the injected animals, were responsible for the decreased 
incidence  of atherosclerosis,  or whether  this was due  to  the presence of the 
injected  surface-active  agents  in  the  circulating  fluids,  or  to  other  factors, 
cannot  now  be  definitely  stated.  It  seems  probable  that  the  surface-active 
agents were present in the blood of the injected animals throughout the course 
of the experiment, and the effect of these agents in stabilizing lipid emulsions is 
well known  (19).  On  the other hand,  it has been shown both in vivo and in 
vitro that elevated phospholipids exert an important stabilizing influence on the 
lipid emulsion  in  hyperlipemic blood  (9,  10),  and  it  is  therefore conceivable 
that the elevation of phospholipid in the Tween 80- and Triton A20-injected 
animals played a role in the decreased incidence of atherosclerosis. This possi- 
bility is further strengthened  by the  observation that cholesterol-fed rabbits 
with  atherosclerosis  were  found  consistently  to  have  relatively  low  blood 
phospholipid levels as compared to their cholesterol levels. A similar disparity 
between blood phospholipid and cholesterol has been reported in chickens in A.  KELLNER,  J'.  W.  CORRELL,  AND  A.  T.  LADD  397 
which atherosclerosis  had been produced by cholesterol feeding (20), and more 
recently,  in human  beings with clinical  evidence of atherosclerosis  (21),  the 
findings  suggesting  that  the decrease in  blood phospholipid with  respect to 
cholesterol,  by altering  the colloidal  stability of the lipid emulsion,  may be 
involved in the pathogenesis of experimental and naturally occurring  athero- 
sclerosis. It would thus seem desirable to study directly the role of phospholipids 
in the pathogenesis of atherosclerosis  by selectively raising  the blood phospho- 
lipid level in cholesterol-fed  animals.  But this is not feasible at present, for the 
addition  of phospholipids or of phospholipid precursors such as choline  and 
inositol to  the diet  of normal  or  cholesterol-fed  rabbits  has  no  appreciable 
effect on blood phospholipid levels  (22), while the intravenous administration 
of phospholipid emulsions gives rise to only slight and transitory elevations of 
the blood phospholipid level (22, 23),  and no procedure has yet been devised 
whereby sustained elevations of blood phospholipids can be produced without 
concomitant increases in blood cholesterol. 
The fact has considerable interest that atherosclerosis developed in some of 
the animals on normal diets that were given repeated intravenous injections of 
Triton A20 (Table III). For it represents the production in the rabbit while on 
a cholesterol-free  diet of atherosclerosis morphologically  indistinguishable from 
that produced by cholesterol feeding, a phenomenon that has not been reported 
heretofore. Furthermore, the observation shows that the effect of intravenously 
injected Tween 80 and Triton A20 in hindering  the development of athero- 
sclerosis is not an absolute one, and it indicates that there may be other factors 
involved in the pathogenesis of atherosclerosis in addition to the levels of blood 
cholesterol and phospholipid. In this connection it should be noted that phos- 
pholipids are probably not the only physiological factors that  influence  the 
solubility of lipids and the stability of lipid emulsions in body fluids. For Cohn 
and  his  coworkers have demonstrated  that  in human plasma almost all the 
lipid is in combination with an alpha- and a beta-globulin, some 25 per cent as 
an  alpha-lipoprotein  and  about  75  per cent as a  beta-lipoprotein  (24),  and 
furthermore,  it  has  been shown  that  this  beta-lipoprotein  is,  under  certain 
conditions, soluble in aqueous media despite the fact that it is composed largely 
of lipid  (25). These lipoproteins probably play an important role in the solu- 
bility and colloidal  stability of the blood lipids,  and the relationship of these 
lipid-protein complexes  to the development of atherosclerosis deserves further 
investigation. 
SUMMARY 
A study was made of the relationship of blood lipids to the development of 
experimental atherosclerosis. 
Rabbits fed a diet containing cholesterol were found to develop hyperlipemia 
characterized by a great increase in blood cholesterol  and a much lesser increase 398  SURFACE-ACTIVE  AGENTS  AND  ATHEROSCLEROSIS 
in  blood  phospholipids;  after  several  weeks  they  manifested  conspicuous 
atherosclerosis of the aorta, as has often been observed by others. Comparable 
rabbits fed the same diets containing added cholesterol were given in addition 
repeated  intravenous injections of  the  surface-active agents Tween  80  and 
Triton A20; these animals developed hyperlipemia which was characterized by 
a great increase in blood cholesterol and an equivalent or even greater increase 
in phospholipids, and they had much less atherosclerosis than did the control 
rabbits fed cholesterol alone. 
In further experiments it was observed that repeated intravenous injections 
of Tween 80 did not result in resorption of previously induced atherosclerosis 
in rabbits. 
The findings are  discussed in relation to the pathogenesis of natural and 
experimental atherosclerosis. 
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